Ronald Blue & Co’s HCA Healthcare HCA Stock Holding History

Ronald Blue & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$8.5M	Buy	97,455 +331	+0.3%	+$28K	0.27%	17
2017 Q1	$8.64M	Buy	97,124 +96	+0.1%	+$8.01K	0.3%	16
2016 Q4	$7.18M	Buy	97,028 +68	+0.1%	+$5.09K	0.28%	20
2016 Q3	$7.33M	Buy	96,960 +16	+0%	+$1.23K	0.3%	14
2016 Q2	$7.47M	Sell	96,944 -500	-0.5%	-$39.5K	0.34%	12
2016 Q1	$7.61M	Hold	97,444	–	–	0.41%	11
2015 Q4	$6.59M	Sell	97,444 -508	-0.5%	-$35.4K	0.35%	19
2015 Q3	$7.58M	Buy	97,952 +388	+0.4%	+$34.4K	0.4%	9
2015 Q2	$8.85M	Buy	97,564 +101	+0.1%	+$8.09K	0.42%	9
2015 Q1	$7.33M	Sell	97,463 -10,727	-10%	-$770K	0.35%	10
2014 Q4	$7.94M	Sell	108,190 -11,340	-9%	-$797K	0.39%	10
2014 Q3	$8.43M	Sell	119,530 -17,800	-13%	-$1.18M	0.55%	9
2014 Q2	$7.74M	Hold	137,330	–	–	0.49%	8
2014 Q1	$7.21M	Hold	137,330	–	–	0.53%	8
2013 Q4	$6.55M	Hold	137,330	–	–	0.49%	11
2013 Q3	$5.87M	Hold	137,330	–	–	0.48%	6
2013 Q2	$4.95M	Buy	+137,330	New	+$5.31M	0.41%	12

Other funds holding HCA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

MAM

Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ronald Blue & Co's HCA Position: Q2 2017 in Review

Ronald Blue & Co increased its HCA Healthcare (HCA) stake by 0.34% in Q2 2017, buying an estimated $28K and bringing the position to 97,455 shares worth $8.5M. The position accounts for 0.27% of the portfolio, ranked #17.

Ronald Blue & Co first reported a position in HCA in Q2 2013 and has held it in 17 quarters since. The position peaked at $8.85M in Q2 2015. 570 funds tracked by Wall St. Rank hold HCA as of Q2 2017.

Ronald Blue & Co held 97,455 shares of HCA Healthcare worth $8.5M as of Q2 2017.
Ronald Blue & Co bought 331 HCA Healthcare shares in Q2 2017, an estimated $28K.
HCA Healthcare made up 0.27% of Ronald Blue & Co's portfolio in Q2 2017, its #17 holding.
Ronald Blue & Co first reported a position in HCA Healthcare in Q2 2013 and has held it in 17 quarters since.
Ronald Blue & Co's HCA Healthcare position peaked at $8.85M in Q2 2015.
570 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.